libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - Други лекарства в нервната система - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
amoxicrid retard 15 % inj. - bg 150 mg/ml
Габрофам ООД - Амоксицилин (като Амоксициллина тригидрат) - инжекционна суспензия - 150 mg/ml - говеда, котки, кучета, овце, прасета
amoxicrid retard 15 % inj. - bg 150 mg/ml
s.c. crida pharm s.r.l - Амоксицилин (като Амоксициллина тригидрат) - инжекционна суспензия - 150 mg/ml - говеда, котки, кучета, овце, прасета
amoxoil retard 150 mg/ml
laboratorios syva, s.a.u - Амоксицилин (тригидрат) - инжекционна суспензия - 150 mg/ml - говеда, котки, кучета, овце, свине
neurotop retard 300 mg prolonged - release tablets
g. l. pharma gmbh - Карбамазепин - 300 mg prolonged - release tablets
neurotop retard 600 mg prolonged - release tablets
g. l. pharma gmbh - Карбамазепин - 600 mg prolonged - release tablets
ketilept retard 150 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 150 mg prolonged - release tablets
ketilept retard 50 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 50 mg prolonged - release tablets
ketilept retard 200 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 200 mg prolonged - release tablets
ketilept retard 300 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 300 mg prolonged - release tablets